Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lipskar AM et al. - Low-dose rapamycin inhibits tumor growth and angiogenesis in human ES without inhibiting the phosphorylation of p70s6k and Akt. Cyclooxygenase 2 levels are inhibited by low-dose treatment of ES with rapamycin. Cyclooxygenase 2 suppression may mediate the antiangiogenic effect of rapamycin in Ewing sarcoma.

Related Articles

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas
Modern Pathology, 11/11/09    Relevance Score: 92%

Histiocytic sarcoma with interdigitating dendritic cell differentiation: A case report with fine needle aspiration cytology and review of literature
Diagnostic Cytopathology, 10/28/09    Relevance Score: 90%

Skeletal metastasis from sarcoma: a report of three cases
European Journal of Orthopaedic Surgery & Traumatology, 10/23/09    Relevance Score: 89%

Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09    Relevance Score: 89%

Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report
Medical Oncology, 10/19/09    Relevance Score: 89%

Today in Surgical Oncology...keeping you current

Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer
Annals of Surgical Oncology, 11/25/09

Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL
Journal of Surgical Oncology, 11/25/09

Single HCC smaller than 2 cm: surgery or ablation
Journal of Hepato-Biliary-Pancreatic Surgery, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address